N-(2-Cyano-2-methylpropyl)-2-(1-((1r,4r)-4-(cyanomethyl)cyclohexyl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl)acetamide

ID: ALA4537718

PubChem CID: 134611580

Max Phase: Preclinical

Molecular Formula: C23H27N7O

Molecular Weight: 417.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C#N)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1

Standard InChI:  InChI=1S/C23H27N7O/c1-23(2,13-25)14-28-20(31)11-19-29-18-12-27-22-17(8-10-26-22)21(18)30(19)16-5-3-15(4-6-16)7-9-24/h8,10,12,15-16H,3-7,11,14H2,1-2H3,(H,26,27)(H,28,31)/t15-,16-

Standard InChI Key:  CRBPNYKHFXDNRW-WKILWMFISA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    6.9188  -26.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6268  -26.8049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3337  -25.5728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3339  -26.3960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1169  -26.6501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6006  -25.9840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1165  -25.3183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9199  -25.5764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6233  -25.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4532  -24.3742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6447  -24.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3152  -25.0334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9991  -23.7662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8018  -23.9383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3469  -23.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0972  -22.5557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2971  -22.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7467  -22.9923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6454  -21.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4444  -22.1215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2451  -22.2979    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2350  -23.5832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4178  -23.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0103  -24.2927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0082  -22.8773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1910  -22.8785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7814  -22.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9642  -22.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1889  -21.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3678  -21.4575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9543  -20.7435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  8  1  2  0
  1  2  1  0
  2  4  2  0
  3  9  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 13 10  1  1
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  6
 19 20  1  0
 20 21  3  0
 11 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
 30 31  3  0
M  END

Alternative Forms

  1. Parent:

    ALA4537718

    ---

Associated Targets(Human)

JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin JAK1/TYK2 (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin JAK3/JAK1 (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.52Molecular Weight (Monoisotopic): 417.2277AlogP: 3.77#Rotatable Bonds: 6
Polar Surface Area: 123.18Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.90CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.63Np Likeness Score: -0.85

References

1. Leonard KA, Madge LA, Krawczuk PJ, Wang A, Kreutter KD, Bacani GM, Chai W, Smith RC, Tichenor MS, Harris MC, Malaviya R, Seierstad M, Johnson ME, Venable JD, Kim S, Hirst GC, Mathur AS, Rao TS, Edwards JP, Rizzolio MC, Koudriakova T..  (2020)  Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease.,  63  (6): [PMID:32134643] [10.1021/acs.jmedchem.9b01439]

Source